Simbec Company Profile

11:55 EST 12th December 2018 | BioPortfolio


News Articles [1 Associated News Articles listed on BioPortfolio]

Acticor Biotech Confirms Simbec-Orion to Make Its First in Patient Study in Acute Ischemic Stroke

Acticor Biotech, a clinical stage biotechnology company involved in the acute phase of thrombotic diseases, including stroke and pulmonary embolism, as part of the development of ...

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

A Study of SENS 401 in Healthy Subjects

Sensorion are the study sponsor and the objective of this study is to investigate the safety and pharmacokinetic (PK) profile of SENS 401 in humans after a single and repeat dose administr...

A Single Dose PK Study of SENS-218 in Healthy Volunteers

This study is to aid the development for the use of SENS-218 outside its marketed therapeutic indications. SENS-218 is available in Asia and is marketed as an anti-emetic (Anti-sickness) d...

More Information about "Simbec" on BioPortfolio

We have published hundreds of Simbec news stories on BioPortfolio along with dozens of Simbec Clinical Trials and PubMed Articles about Simbec for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Simbec Companies in our database. You can also find out about relevant Simbec Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record